abstract |
Described herein are compounds that are useful as protein kinase inhibitors having the formula: (I) where R1-4, Q, and T are described in the specification. Th e compounds are useful for treating disease states in mammals that are alleviated by a prote in kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, an d cardiovascular disease. |